Cellemedy
PrivateLast Round
Series A
Sep 20, 2023
Total Funding Raised
$11.15M
Company Overview
Cellemedy operates in Healthcare & Life Sciences and is based in South Korea. Its latest recorded funding round was a Series A round in September 2023.
Cellemedy is a biotechnology company that develops next-generation therapeutic proteins and cancer immunotherapy treatments using its proprietary T-sphaera ferritin nano-cage platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellemedy Comparables
Compare Cellemedy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pinotbio | 83% | |
| Archon Biosciences | 81% | |
| GI Innovation Inc. | 77% |
For institutional investors. Book with your work email.
Cellemedy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 20, 2023 | ||||
| Seed | Dec 1, 2020 |
For institutional investors. Book with your work email.
Cellemedy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CKD Venture Capital | Series A |
| DAYLI Partners | Seed, Series A |
| IBK Capital | Series A |
| Stonebridge Ventures | Series A, Seed |
| IMM Investment | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 20, 2023
$8M round led by DAYLI Partners
- Dec 1, 2020
$3.65M raised from DAYLI Partners, IMM Investment, and Stonebridge Ventures.
For institutional investors. Book with your work email.
Cellemedy Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cellemedy's valuation, stock price, and market status.
Is Cellemedy a public or private company?
Cellemedy is a private company.
What is the current stock price of Cellemedy?
Cellemedy is a private company, so its shares have no public market price. Caplight tracks Cellemedy's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cellemedy worth (valuation)?
Valuation information for Cellemedy is not publicly available.
Can I buy Cellemedy stock?
Cellemedy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cellemedy's last funding round?
Cellemedy's most recent funding round was Series A on September 20, 2023.
Who are the main investors in Cellemedy?
Key investors in Cellemedy include DAYLI Partners.
Will Cellemedy IPO soon?
No public IPO plans have been announced for Cellemedy.
How can I track Cellemedy secondary market activity?
Caplight tracks bids, offers, and trades in Cellemedy's shares on secondary markets.